Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce J Brew

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Journal of Neurovirology|August 15, 2013
Improved neurocognitive test performance in both arms of the SMART study: impact of practice effectBirgit Grund, Edwina J Wright, Bruce J Brew, et al.
The Journal of Infectious Diseases|November 20, 2004
Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementiaMelissa Churchill, Jasminka Sterjovski, Lachlan Gray, et al.
Plos One|April 25, 2013
The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytesLachlan R Gray, Gilda Tachedjian, Anne M Ellett, et al.
The Journal of Infectious Diseases|March 6, 2013
Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infectionMichael J Peluso, Dieter J Meyerhoff, Richard W Price, et al.
Plos Clinical Trials|April 3, 2007
Factors in AIDS dementia complex trial design: results and lessons from the abacavir trialBruce J Brew, Mark Halman, Jose Catalan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2021
Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter StudyGustaf Ulfhammer, Arvid Edén, Andrea Antinori, et al.
Journal of Virology|March 27, 2009
Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brainLachlan Gray, Michael Roche, Melissa J Churchill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2005
Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patientsLucette A Cysique, Bruce J Brew, Mark Halman, et al.
Annals of Clinical and Translational Neurology|June 15, 2023
The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASCLucette A Cysique, David Jakabek, Sophia G Bracken, et al.
Retrovirology|September 25, 2007
Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivoPaul R Gorry, Dale A McPhee, Erin Verity, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Journal of Neurovirology|August 15, 2013
Improved neurocognitive test performance in both arms of the SMART study: impact of practice effectBirgit Grund, Edwina J Wright, Bruce J Brew, et al.
The Journal of Infectious Diseases|November 20, 2004
Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementiaMelissa Churchill, Jasminka Sterjovski, Lachlan Gray, et al.
Plos One|April 25, 2013
The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytesLachlan R Gray, Gilda Tachedjian, Anne M Ellett, et al.
The Journal of Infectious Diseases|March 6, 2013
Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infectionMichael J Peluso, Dieter J Meyerhoff, Richard W Price, et al.
Plos Clinical Trials|April 3, 2007
Factors in AIDS dementia complex trial design: results and lessons from the abacavir trialBruce J Brew, Mark Halman, Jose Catalan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2021
Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter StudyGustaf Ulfhammer, Arvid Edén, Andrea Antinori, et al.
Journal of Virology|March 27, 2009
Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brainLachlan Gray, Michael Roche, Melissa J Churchill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2005
Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patientsLucette A Cysique, Bruce J Brew, Mark Halman, et al.
Annals of Clinical and Translational Neurology|June 15, 2023
The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASCLucette A Cysique, David Jakabek, Sophia G Bracken, et al.
Retrovirology|September 25, 2007
Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivoPaul R Gorry, Dale A McPhee, Erin Verity, et al.
Pageof 18